pharmaceutical drugs
671 projects
HEIndividual fellowship2027–2029France
JAK2-TB · Human JAK2 genotypes underlying tuberculosis
3 partners
HEDoctoral network2027–2031United Kingdom
RADICALLY · Enantioselective Catalysis for Radical Transformations
13 partners · 6 countries
HEIndividual fellowship2027–2029Ireland
AURa · Antibacterial and pro-Angiogenic electroconductive scaffold for functional woUnd Regen-eration with neurogenic cues
HEIndividual fellowship2027–2029Sweden
SHINE-Vax · Smart Hydrogel Microneedle Patches for mRNA Nanoparticle Vaccination
HEIndividual fellowship2027–2029Finland
UNFENCED · Unravelling Nanoplastics: The Fate of Emerging Contaminants and Nanoplastics Concomitance in Environmental Dynamics
HEIndividual fellowship2027–2030Germany
EvoComb · Evolution under sequential antibiotic combinations: integrating clinical data into models and experiments to tackle resistance
3 partners · 3 countries
HEIndividual fellowship2027–2028Denmark
IRGOP · Immunometabolic Reprogramming via a Gut-derived Organoid Platform
HEIndividual fellowship2027–2028Austria
GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
2 partners · 2 countries
HEIndividual fellowship2027–2029Spain
CLUSTERS · Controlling Polymorphism Using Optimal Electric Fields
HEStaff exchange2027–2030Norway
BIOVIRAL · Biofuel-based Innovation for the Optimization of VIRAL inhibition through alcohol-ligand modeling
3 partners · 3 countries
HEIndividual fellowship2027–2029Italy
MCG-QUAD · Machine Learning-Enhanced Coarse-Grained Modelling of Telomeric G-Quadruplex Multimers: A Multiscale Study
HEIndividual fellowship2026–2029France
MIND · Multiscale Investigation of the Neural and electrochemical correlates of temporal Distortions
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
VaccinNate · From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants
HEIndividual fellowship2026–2028United Kingdom
SYNTH HORSE · Trojan‑Horse Siderophore–Teixobactin Conjugates to Defeat Gram‑Negative Superbugs
2 partners · 2 countries
HEIndividual fellowship2026–2028United Kingdom
M2-CPID · Multiscale Modelling of Microfluidic Cell Mechanoporation for Intracellular Gene Delivery
HEIndividual fellowship2026–2028Spain
semiQ2 · Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation
HEIndividual fellowship2026–2028France
PRISM · Beyond the binary: ProgRammIng of Sexual immune identity from thyMus to tissues
HEIndividual fellowship2026–2028Germany
HALOGEN · HALOgenase-driven high-throughput experimentation and GENome mining
HEIndividual fellowship2026–2028Spain
CESAm-HAT · Carbonyl-catalyzed EnantioSelective synthesis of primary Amines via Hydrogen-Atom Transfer activation
HEIndividual fellowship2026–2028France
PG-BIR · Elucidating the Role of Peptidoglycan Fragments in β-Lactam-Induced Host Immune Responses
HEIndividual fellowship2026–2028United Kingdom
AtropEnzymes · Engineering new enzymatic platforms for atroposelective C–N bond formation
2 partners · 2 countries
HEIndividual fellowship2026–2028United Kingdom
OLIGNA · Orthogonal Ligase Enzymes for Assembly of Modified Nucleic Acids
HEIndividual fellowship2026–2028Ireland
FluorNano · Fluorinated polymer nanoparticles for mRNA-based cancer therapy
2 partners · 2 countries
HEIndividual fellowship2026–2028France
